Mid-size Drugs Based On Peptides and Peptidomimetics: A New Drug Category (1st ed. 2018 edition.)

This brief describes studies conducted by the authors on mid-size drugs utilizing peptides and peptidomimetics, and on the development of anti-HIV agents.

To date, several peptidomimetics that mimic primary, secondary, and tertiary structures of peptides have been developed to maintain and improve biological activities and actions of peptides.